Application 020405
- Type
- NDA
- Sponsor
- CONCORDIA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.0625MG | Yes | No |
| 002 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.125MG | Yes | No |
| 003 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.1875MG | Yes | No |
| 004 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.25MG | Yes | Yes |
| 005 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.375MG | No | No |
| 006 | LANOXIN | DIGOXIN | TABLET;ORAL | 0.5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020405-001 | LANOXIN | DIGOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020405-002 | LANOXIN | DIGOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 |
| N020405-003 | LANOXIN | DIGOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | |
| N020405-004 | LANOXIN | DIGOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 |
| N020405-005 | LANOXIN | DIGOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | ||
| N020405-006 | LANOXIN | DIGOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020405-001 | AB |
| N020405-002 | AB |
| N020405-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-005 | LANOXIN | 0.375MG | TABLET / ORAL | 1997-09-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020405-006 | LANOXIN | 0.5MG | TABLET / ORAL | 1997-09-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-001 | LANOXIN | 0.0625MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-002 | LANOXIN | 0.125MG | TABLET / ORAL | AB | RLD | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-003 | LANOXIN | 0.1875MG | TABLET / ORAL | RLD | 1997-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020405-004 | LANOXIN | 0.25MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020405-004 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N020405-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N020405-002 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N020405-004 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N020405-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N020405-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N020405-004 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020405-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020405-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020405-004 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020405-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020405-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020405-004 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020405-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020405-002 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020405-004 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020405-001 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020405-002 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020405-004 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N020405-001 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N020405-002 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N020405-004 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N020405-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N020405-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N020405-004 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020405-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020405-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020405-004 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N020405-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N020405-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N020405-004 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N020405-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N020405-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N020405-004 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020405-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020405-002 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020405-004 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020405-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020405-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020405-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LANOXIN | DIGOXIN | Advanz Pharma (US) Corp. | d91e3646-4c63-4512-ab22-db39c085c4dc | 2024-12-05 | Warnings, Adverse reactions | 020405 NDA020405 59212-249 59212-245 59212-242 59212-240 |
| LANOXIN | DIGOXIN | Aphena Pharma Solutions - Tennessee, LLC | f6c7ca21-1c76-4838-8fb9-e1bec6001d8b | 2019-05-08 | Warnings, Adverse reactions | 020405 NDA020405 71610-019 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0615-7935 | DIGOXIN | DIGOXIN | NCS HealthCare of KY, Inc dba Vangard Labs | NDA AUTHORIZED GENERIC | Current |
| 49884-494 | DIGOXIN | DIGOXIN | Par Pharmaceutical Inc. | NDA AUTHORIZED GENERIC | Current |
| 49884-514 | DIGOXIN | DIGOXIN | Par Pharmaceutical Inc. | NDA AUTHORIZED GENERIC | Current |
| 53808-1006 | DIGOXIN | DIGOXIN | State of Florida DOH Central Pharmacy | NDA AUTHORIZED GENERIC | Current |
| 55154-6726 | LANOXIN | digoxin | Cardinal Health | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-240 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-242 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-245 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-249 | LANOXIN | digoxin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 65084-455 | LANOXIN | digoxin | Mckesson Rxpak Inc | NDA | Current |
| 66267-078 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66267-078 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66267-443 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66267-443 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 68071-3011 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 68071-3011 | DIGOXIN | DIGOXIN | NuCare Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 70518-0298 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-0338 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-0848 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-0848 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-0913 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-0913 | DIGOXIN | DIGOXIN | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 71610-019 | LANOXIN | digoxin | Aphena Pharma Solutions - Tennessee, LLC | NDA | Current |
| 71610-019 | LANOXIN | digoxin | Aphena Pharma Solutions - Tennessee, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78312 | SUPPL | 2024-04-30 |
| 78304 | SUPPL | 2024-04-30 |
| 57815 | SUPPL | 2019-02-27 |
| 57799 | SUPPL | 2019-02-25 |
| 55337 | SUPPL | 2018-08-28 |
| 55301 | SUPPL | 2018-08-24 |
| 46136 | SUPPL | 2016-12-13 |
| 46020 | SUPPL | 2016-12-05 |
| 12542 | SUPPL | 2015-07-30 |
| 24916 | SUPPL | 2015-07-29 |
| 24915 | SUPPL | 2013-10-21 |
| 12541 | SUPPL | 2013-10-18 |
| 2485 | SUPPL | 2012-08-16 |
| 34607 | SUPPL | 2012-08-15 |
| 2486 | SUPPL | 2011-11-16 |
| 34608 | SUPPL | 2011-11-14 |
| 20635 | ORIG | 2010-03-03 |
| 2484 | SUPPL | 2010-02-17 |
| 34606 | SUPPL | 2010-02-16 |